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implantation), through the analysis of hemodynamic data to
compare the three methods in monitoring hemodynamic parame-
ters, and to know which is superiority in acute inferior myocardial
infarction.
RESULTS In this experiment set range of rehydration, by comparing
the PiCCO monitor with the Swan - Ganz catheter before and after
rehydration, CO has good correlation (r ¼ 0.9667, p ¼ 0.9667); CVP and
PCWP also have good correlation (r ¼ 0.6135, p ¼ 0.6135). The MAP and
CO have good correlation with EVLWI (r ¼ 0.984, p ¼ 0.000 and r ¼
0.981, p ¼ 0.000 respectively). PiCCO and ultrasonic parameters of
CO, CI, GEF/EF have good correlation (r ¼ 0.871, p ¼ 0.003; r ¼ 0.660;
p ¼ 0.010; r ¼ 0.652, p ¼ 0.001).
CONCLUSIONS In the case of same treatment goals, PiCCO, Swan-
Ganz catheter and echocardiography can effectively monitor the
hemodynamic changes of acute inferior myocardial infarction. Three
methods have their own advantages. First, echocardiography has
less noninvasive monitoring parameters, and it can not monitoring
the real-time hemodynamic changes; second, the Swan-Ganz is ac-
curate, but is difﬁcult to operate, and its trauma is larger than other
methods and the indwelling time is short. Third, the PiCCO as a
minimally invasive hemodynamic monitoring method, it can pro-
vide dynamic, continuous, accurate and perfect hemodynamic pa-
rameters, and can also show the speciﬁc parameters as whole heart
end-diastolic volume (GEDV) and lung water index (EVLWI). PiCCO
is convenient for clinical application and with better clinical
feasibility.GW26-e0753
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OBJECTIVES To compare the long-term outcomes of drug-eluting
stent (DES) with bare-metal stent (BMS) implantation in patients with
acute coronary syndrome (ACS).
METHODS The study included 1143 patients with ACS who under-
went stent implantation from January 2001 to December 2010. Of
them there were male 892 (78.0%) and female 251 (22.0%), and there
were 673 patients (58.9%) with unstable anginal, 86 patients (7.5%)
with non-ST elevation myocardial infarction and 384 patients
(33.6%) with acute STEMI. The average age of the cases was
59.029.97 (range 33–86) years old. The coronary angiography
showed stenosis with 75%-100% in a native coronary artery. Out of
1143 subjects there were 122 cases (10.7%) with CTO lesions. The
study subjects were divided into BMS group (n ¼ 479) who received
a BMS implantation and DES group (n ¼ 664) who received a DES
implantation. All patients were followed by clinical and angiography
for a mean follow-up period of (70.26  35.94) months (range 12–172
months). The main endpoint was the occurrence of the ﬁrst major
adverse cardiac event (MACE), deﬁned as death, nonfatal recurrent
myocardial infarction, target lesion revascularization (TLR), target
vessel revascularization (TVR), very late in-stent thrombosis (VST)
and CABG.
RESULTS The signiﬁcant differences of baseline characteristics in
two groups were not found for age, gender, hypertension, hyper-
lipidemia, diabetes, smoking, heart failure, previous cerebral stroke
and history of OMI. CTO lesions (11.7%, 56 cases) and LM lesions
(2.5%, 12 cases) in BMS group were not signiﬁcant difference
compared with those (9.9%, 66 cases and 4.7%, 31 cases) in DES.
The mean number of lesion coronary branches in BMS and DES was
dividedly 1.450.64 and 1.660.74 (P>0.001). The number of
implanted stents (1.760.90) in DES group was more than that
(0.450.77) in BMS group (P<0.001). The length and diameter of
the stents implanted were respectively (3.190.40) mm in BMS vs
(3.13 0.38) mm in DES (P¼0.016) and (19.636.79) mm in BMS vs
(20.805.32) mm in DES (P¼0.001). During follow-up the cumula-
tive MACE rate was 35.3% (169 cases) in BMS and 20.2% (134 cases)
in DES (P<0.001). The mortality of all-cause was 14.2% (68 cases) in
BMS and 5.0% (33 cases) in DES group (P<0.01). The TLR rate in
BMS was signiﬁcantly higher than 6.2% (41cases) in DES (P<0.01).
The TVR rate (5.6%) in BMS was similar to that (5.4%) in DES. Thenonfatal recurrent myocardial infarction and VST were 0 in BMS,
and were respectively 1.2% (8 cases) and 1.1% (7cases) in DES. Heart
failure (0.4%) and CABG (0.4%) in BMS were similar to those (1.4%
and 0.3%) in DES. The rates of in-stent restenosis (31.1%, 102 cases)
in BMS were higher than those (16.1%, 95 cases) in DES (P<0.01).
The restenosis rate of in-segment of stent (17.4%) in BMS and
(13.9%) in DES was similar.
CONCLUSIONS The MACE rate in groups was signiﬁcant difference in
long-term follow-up. The cumulative MACE rate, the mortality of all-
cause death and TLR rate in BMS were higher than those in DES.GW26-e0769
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OBJECTIVES In this study, we aimed to study the mechanisms
for impaired the P2Y12 receptor inhibitor ticagrelor response in
coronary artery disease (CAD) and diabetes mellitus (DM).
METHODS The study involved 53 ACS patients admitted between
March 2014 and 2015 to our hospital, 23 patients were diagnosed CAD
only; 30 patients were diagnosed coronary artery disease (CAD) with
diabetes mellitus (DM), They all took aspirin 100 mg/d p.o q24h and
ticagrelor 90mg/d p.o q12h. Before and at various times (0.5, 1, 2, 4, 6,
and 24 h) after 180mg load dose of ticagrelor, blood was collected and
measure. We used a comprehensive methodological approach
embracing PK and PD assessments and ex vivo and in vitro evalua-
tions, and its major active metabolite AR-C124910XX exposure was
also determined.
RESULTS PD assessments signiﬁcantly showed that residual platelet
reactivity after 24-h treatment with ticagrelor was higher in patients
with diabetes mellitus than in non- diabetes mellitus patients. AR-
C124910XX exposure was lower in diabetes mellitus than in non-
diabetes mellitus patients.
CONCLUSIONS Our data suggested that ticagrelor -mediated
platelet P2Y12 receptor blockade responses are impaired in patients
with diabetes mellitus compared with non- diabetes mellitus
patients.GW26-e1076
The signiﬁcance of platelet volume changes in acute
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OBJECTIVES This study sought to evaluate clinical value of ACS and
its relationship with coronary artery disease through the Mean
platelet volume (MPV) and platelet large cell rate (P-LCR) changes in
patients with ACS.
METHODS A total of 378 patients was divided into the ACS group
and the control group. A total of 273 patients in ACS group,
including ST-segment elevation myocardial infarction (STEMI) of 94
cases patients, non-ST segment elevation myocardial infarction
(NSTEMI) of 62 cases patients, unstable angina(UA) 117 cases of
patients, selected the same phase hospital diagnosed with cardiac
neurosis patients 85 cases as control group. All patients were
collected elbow vein blood samples, including routine blood all
items, troponin (cTNI), brain natriuretic peptide precursor (NT -
proBNP), renal function, D - dimer testing ect. All patients were
performed coronary angiography examination, take Gensini score as
an index of the severity of coronary artery lesions. Selected 60
patients of ACS group, who treated by PCI and regular oral clopi-
dogrel, and were followed up for 6 months, according to the pres-
ence of MACE can be divided into MACE group and non- MACE
group, review of MPV, P-LCR after following up for 1 month.
Selected 60 patients of ACS group, who treated by PCI and regular
oral clopidogrel, and were followed up for 6 months, according to
the presence of MACE events can be divided into MACE group and
non- MACE group, review of MPV, P - the LCR after following up
for 1 month. Using multiariable logistic regression analysis the
relevance between Gensini score and MPV, P-LCR. Using the
